| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/15/2014 | EP2683244A1 Heterocyclic modulators of lipid synthesis |
| 01/15/2014 | CN103517906A 4H-imidazo[1,2-a]imidazoles for electronic applications |
| 01/15/2014 | CN103517905A New hexahydropyrroloimidazolone compounds |
| 01/15/2014 | CN103517904A Alpha helix mimetics and methods relating thereto |
| 01/15/2014 | CN103509028A Method for preparing chlorophyll cuprate and sodium copper chlorophyll |
| 01/15/2014 | CN103509027A Preparation method for florasulam |
| 01/15/2014 | CN103509026A Preparation method of benzo[4,5]imidazo[1,2-alpha]pyrimidine-3-carboxamide derivative |
| 01/15/2014 | CN103509025A Preparation method of epinastine hydrochloride and intermediate thereof |
| 01/15/2014 | CN103509024A Pyrimidobenzoazepine compound and application thereof as anti-tumor medicine |
| 01/15/2014 | CN103508930A Bis(aminodithioformate)-1,3-propane diester compound, and synthesis method, pharmaceutical composition and use thereof |
| 01/15/2014 | CN102702205B Preparation method of sitagliptin |
| 01/15/2014 | CN102653541B Porphyrin compound as well as preparation method and application of porphyrin compound |
| 01/15/2014 | CN102464659B Licopyrinobuter compound crystal forms, preparation method, and use thereof |
| 01/15/2014 | CN102413693B Nematocidal sulfonamides |
| 01/15/2014 | CN102408428B 1,2-oxinane pyrazolidone compounds and preparation method and applications thereof |
| 01/15/2014 | CN102329319B Novel crystal form for temozolomide, method for preparing temozolomide and medicinal composition of temozolomide |
| 01/15/2014 | CN102203067B Hedgehog pathway modulators |
| 01/15/2014 | CN101941975B Method for preparing heme from animal blood corpuscle powder serving as raw material |
| 01/15/2014 | CN101878217B Agent for prevention and/or treatment of skin diseases |
| 01/14/2014 | US8629269 Dye for a dye-sensitised solar cell, and a solar cell comprising the same |
| 01/14/2014 | US8629154 Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-HT6 receptors and methods for production and the use thereof |
| 01/14/2014 | US8629152 Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
| 01/14/2014 | US8629143 Potassium channel modulators |
| 01/14/2014 | US8629142 Modulators of toll-like receptors |
| 01/14/2014 | US8629134 Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-jk][1]-benzazepin-2[1H]-one and zilpaterol |
| 01/14/2014 | US8629133 Dispiropyrrolidine derivatives |
| 01/14/2014 | US8628975 Methods and kits using extended rhodamine dyes |
| 01/14/2014 | US8628864 Indolo[3,2,1-jk]carbazole compound and organic light-emitting device containing the same |
| 01/14/2014 | CA2624491C Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 01/09/2014 | WO2014008197A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/09/2014 | WO2014006572A1 Selective pi3k delta inhibitors |
| 01/09/2014 | WO2014006091A1 Ticagrelor adducts with divalent metal salts |
| 01/09/2014 | WO2014005443A1 Method for preparing selective anticoagulant ticagrelor and the intermediate thereof |
| 01/09/2014 | WO2014005217A1 Protein kinase inhibitors |
| 01/09/2014 | WO2013124026A8 8 - substituted 2 -amino - [1,2,4] triazolo [1, 5 -a] pyrazines as syk tryrosine kinase inhibitors and gcn2 serin kinase inhibitors |
| 01/09/2014 | WO2012135944A9 Protein kinase inhibitors |
| 01/09/2014 | US20140011989 Paa nanoparticles for tumor treatment and imaging |
| 01/09/2014 | US20140011988 Dibenzo[B,F][1,4]Oxazepin-11-yl-N-Hydroxybenzamides as HDAC Inhibitors |
| 01/09/2014 | US20140011985 Targeted Cancer Therapy Conjugates Using Porphyrins and Porphyrin-like Molecules and Various Cytotoxic Agents |
| 01/09/2014 | US20140011961 Precursor compound connected to solid support for manufacturing 18f radiopharmaceutical, method for manufacturing same, and application thereof |
| 01/09/2014 | US20140011827 Piperidinone carboxamide spirohydantoin cgrp receptor antagonists |
| 01/09/2014 | US20140011819 Novel selective pi3k delta inhibitors |
| 01/09/2014 | US20140011810 Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith |
| 01/09/2014 | US20140011805 Inhibitors of the bmp signaling pathway |
| 01/09/2014 | US20140011800 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/09/2014 | US20140011798 Imidazopyrrolidinone compounds |
| 01/09/2014 | US20140011795 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases |
| 01/09/2014 | US20140011794 Substituted porphyrins |
| 01/09/2014 | US20140011783 Organic compounds |
| 01/09/2014 | US20140011770 Compositions and methods for inhibition of the jak pathway |
| 01/09/2014 | CA2878332A1 Protein kinase inhibitors |
| 01/09/2014 | CA2877999A1 Heterocyclic modulators of lipid synthesis |
| 01/09/2014 | CA2877541A1 Ticagrelor adducts with divalent metal salts |
| 01/09/2014 | CA2876995A1 Selective pi3k delta inhibitors |
| 01/08/2014 | EP2682394A1 1H-pyrazolo[3,4-b]pyridin-triazine derivatives and their use for the treatment or the prevention of cardiovascular diseases |
| 01/08/2014 | EP2681221A1 Tricyclic inhibitors of kinases |
| 01/08/2014 | EP2681220A2 Novel salts of dpp-iv inhibitor |
| 01/08/2014 | EP2681219A1 6,7-dihydro-pyrazolo[1,5-a]pyrazin-4-ylamine derivatives useful as inhibitors of beta-secretase (bace) |
| 01/08/2014 | EP2681218A1 IMIDAZO[5,1-f][1,2,4]TRIAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 01/08/2014 | EP2680852A1 Pharmaceutically active disubstituted triazine derivatives |
| 01/08/2014 | EP2680851A2 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors |
| 01/08/2014 | EP2283021B1 Switchable special effect substances |
| 01/08/2014 | CN103502250A Novel antifungal 5,6-dihydro-4h-pyrrolo[1,2-a][1,4]benzo- diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives |
| 01/08/2014 | CN103502249A Azaindole derivatives as tyrosine kinase inhibitors |
| 01/08/2014 | CN103502248A Pyrazolo pyrimidine derivatives |
| 01/08/2014 | CN103502217A Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
| 01/08/2014 | CN103497197A Method for preparing phthalocyanine micro-nano structures by utilizing solvent interface diffusion |
| 01/08/2014 | CN103497196A Polynitrogen tricyclic compound, preparation method and application thereof |
| 01/08/2014 | CN103497195A Conivaptan-hydrochloride novel crystal form and preparation method thereof |
| 01/08/2014 | CN103497194A Multi-nitrogen bicyclic compound as well as preparation method and applications of multi-nitrogen bicyclic compound |
| 01/08/2014 | CN103497193A Derivative with 1,2,4-triazine skeleton structure and synthesis method thereof |
| 01/08/2014 | CN103497192A Modulators of TOLL-like receptors |
| 01/08/2014 | CN103497173A Novel compound having heterocyclic ring |
| 01/08/2014 | CN103496692A Method for preparing two-dimensional nanomaterial by utilizing liquid ammonia/alkali metal solution |
| 01/07/2014 | US8624026 Method of preparing sitagliptin and intermediates used therein |
| 01/07/2014 | US8623901 Compounds for the treatment of CNS disorders |
| 01/07/2014 | US8623885 Fused tricyclic dual inhibitors of CDK 4/6 and FLT3 |
| 01/07/2014 | US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 01/07/2014 | US8623880 Fused pyrimidine-dione derivatives as TRPA1 modulators |
| 01/07/2014 | US8623879 1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-D] pyrimidin-4-one derivates and their use as PDE9A modulators |
| 01/07/2014 | US8623876 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/07/2014 | US8623869 Compounds useful as inhibitors of ATR kinase |
| 01/07/2014 | US8623868 Processes of making and using pharmaceutical formulations of antineoplastic agents |
| 01/07/2014 | US8623862 Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |
| 01/07/2014 | CA2611438C Cyclic anilino-pyridinotriazines |
| 01/06/2014 | CA2782774A1 Protein kinase inhibitors |
| 01/03/2014 | WO2014004863A2 Compounds, compositions, and therapeutic uses thereof |
| 01/03/2014 | WO2014004416A1 Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| 01/03/2014 | WO2014002705A1 Near-infrared absorbing agent and near-infrared absorbing composition |
| 01/03/2014 | WO2014001973A1 NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS |
| 01/03/2014 | WO2014000719A1 Novel pharmaceutical solid forms of (1s,2s,3r,5s)-3-[7-[(1r,2s)-2-(3,4difluorophenyl)cyclopropylamino]-5-(propylthio)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-3yl]-5-(2-hydroxyethoxy)cyclopentane-l,2-diol |
| 01/03/2014 | WO2014000713A1 NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS |
| 01/03/2014 | WO2014000686A1 Pyrimidobenzoazepine compound and use thereof as antitumour drug |
| 01/03/2014 | WO2014000541A1 Acyclic nucleotide analogue, preparation method therefor, and application thereof |
| 01/03/2014 | WO2014000455A1 Chiral five-membered bicyclic guanidine compound, and preparation method and application thereof |
| 01/03/2014 | WO2013166276A4 Triazolopyridazine compounds, use as inhibitors of the kinase lrrk2, and methods for preparation thereof |
| 01/03/2014 | WO2013003586A8 Quinazolines as therapeutic compounds and related methods of use |
| 01/03/2014 | CA2878054A1 Novel 4-(substituted-amino)-7h-pyrrolo[2,3-d]pyrimidines as lrrk2 inhibitors |
| 01/03/2014 | CA2878049A1 Novel fused pyridine derivatives useful as c-met tyrosine kinase inhibitors |